Anti-Human CD3 (Muromonab Biosimilar)
英诺赛图(InnoCyto)的 Anti-Human CD3 (Muromonab Biosimilar)(克隆 Muromonab) 为人源 IgG2 抗体,靶向 CD3(别名 T3 等),适用于流式细胞术。提供 1 mg、5 mg、20 mg 规格,目录价 ¥1,695 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 Anti-Human CD3 (Muromonab Biosimilar)(克隆 Muromonab) 为人源 IgG2 抗体,靶向 CD3(别名 T3 等),适用于流式细胞术。提供 1 mg、5 mg、20 mg 规格,目录价 ¥1,695 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
503901 | 1 mg | ¥1,695
503902 | 5 mg | ¥4,068
503903 | 20 mg | ¥12,204
Product Details
Product Description|Muromonab Biosimilar, CD3 Monoclonal Antibody
Regulatory Status|RUO
Species specificity|Human
Storage Conditions|4ºC
Maximal Shelf Life|12 months
See All Formats|Clone Muromonab
Background Information
Muromonab, also known as OKT3, is a murine-derived monoclonal antibody belonging to the immunoglobulin G2a (IgG2a) subclass. It was the first monoclonal antibody developed to specifically target the human CD3 epsilon (CD3ε) subunit—a component of the T-cell receptor (TCR)–CD3 complex located on the surface of T lymphocytes. Structurally, Muromonab is a full-length IgG molecule with a molecular weight of approximately 150 kilodaltons (kDa). It is composed of two identical heavy chains and two identical light chains, linked by interchain disulfide bonds, forming the typical Y-shaped configuration characteristic of immunoglobulins. Each heavy chain contains variable (VH) and constant (CH) domains, while each light chain includes variable (VL) and constant (CL) domains. The molecule is produced by hybridoma technology using murine B-lymphocytes fused with myeloma cells, ensuring high-yield monoclonal antibody production.
The antigen-binding regions of Muromonab are located within the complementarity-determining regions (CDRs) of its VH and VL domains. These CDR loops form the antibody’s paratope, which engages the CD3ε epitope through a network of hydrogen bonds and hydrophobic interactions with nanomolar affinity. The CD3ε subunit plays a critical role in signal transduction following T-cell receptor engagement with peptide–major histocompatibility complex (MHC) molecules. By binding to CD3, Muromonab perturbs TCR–CD3 complex organization, blocking antigen recognition and interrupting downstream signaling cascades involving phosphorylation of ITAMs (immunoreceptor tyrosine-based activation motifs) and activation of intracellular kinases such as Lck and ZAP-70. This interference leads to functional modulation of T-cell activation in experimental systems.
The Fc (fragment crystallizable) region of the IgG2a isotype confers structural stability and can engage Fc gamma receptors (FcγRs), allowing potential secondary immune effects such as antibody-dependent cellular cytotoxicity (ADCC). Overall, Muromonab exemplifies early monoclonal antibody engineering, integrating murine epitope specificity with well-defined IgG architecture to probe receptor-mediated signaling and immune cell regulation mechanisms in molecular immunology research.
Data Sheets
Cat # Size Price Quantity 5039011 mg Add to Cart5039025 mg Add to Cart50390320 mg Add to Cart
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). Anti-Human CD3 (Muromonab Biosimilar)(503901)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/anti-human-cd3-muromonab-biosimilar.html.
TeleVM. (2026, November 12). Anti-Human CD3 (Muromonab Biosimilar)(503901). 产品目录. https://www.suprotek.cn/products/item/anti-human-cd3-muromonab-biosimilar.html
@misc{biocsp_item_anti_human_cd3_muromonab_biosimilar,
title = {Anti-Human CD3 (Muromonab Biosimilar)(503901)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/anti-human-cd3-muromonab-biosimilar.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源